Zeyu Xing

580 total citations
29 papers, 320 citations indexed

About

Zeyu Xing is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zeyu Xing has authored 29 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Zeyu Xing's work include MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zeyu Xing is often cited by papers focused on MicroRNA in disease regulation (5 papers), Circular RNAs in diseases (5 papers) and Cancer-related molecular mechanisms research (5 papers). Zeyu Xing collaborates with scholars based in China, United States and Australia. Zeyu Xing's co-authors include Menglu Zhang, Kexin Feng, Xin Wang, Jiaqi Liu, Jiaqi Liu, Xiang Wang, Xiang Wang, Gang Liu, Jiaqi Liu and Yalun Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zeyu Xing

28 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zeyu Xing China 11 211 160 76 36 27 29 320
Samaneh Adelian Iran 10 202 1.0× 126 0.8× 84 1.1× 48 1.3× 45 1.7× 13 310
Rongxia Liao China 10 292 1.4× 245 1.5× 118 1.6× 28 0.8× 32 1.2× 18 429
Federico Lucantoni Spain 10 183 0.9× 84 0.5× 75 1.0× 28 0.8× 36 1.3× 14 333
Zhousan Zheng China 10 255 1.2× 153 1.0× 58 0.8× 64 1.8× 17 0.6× 16 347
Giulia Brisotto Italy 9 217 1.0× 162 1.0× 87 1.1× 38 1.1× 17 0.6× 22 357
Yue‐Ju Li Taiwan 9 243 1.2× 174 1.1× 71 0.9× 21 0.6× 29 1.1× 11 326
Brijesh Kumar United States 11 168 0.8× 99 0.6× 94 1.2× 53 1.5× 31 1.1× 18 314
Hongchao Tang China 10 171 0.8× 107 0.7× 102 1.3× 49 1.4× 55 2.0× 25 288
Wu-Ping Zheng China 11 225 1.1× 124 0.8× 49 0.6× 57 1.6× 55 2.0× 27 349
Anna Tyutyunnykova Ukraine 3 198 0.9× 122 0.8× 180 2.4× 38 1.1× 35 1.3× 4 336

Countries citing papers authored by Zeyu Xing

Since Specialization
Citations

This map shows the geographic impact of Zeyu Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeyu Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeyu Xing more than expected).

Fields of papers citing papers by Zeyu Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeyu Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeyu Xing. The network helps show where Zeyu Xing may publish in the future.

Co-authorship network of co-authors of Zeyu Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Zeyu Xing. A scholar is included among the top collaborators of Zeyu Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeyu Xing. Zeyu Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dongdong, et al.. (2025). Unveiling the roles of HIPK2 in atherosclerosis: Insights into the β-catenin/STAT1 signaling cascade and the involvement of SENP1. Biochemical Pharmacology. 237. 116911–116911. 2 indexed citations
2.
Xing, Zeyu, Mingyang Du, Jie Chen, et al.. (2023). LETMD1, a target of KLF4, hinders endothelial inflammation and pyroptosis: A protective mechanism in the pathogenesis of atherosclerosis. Cellular Signalling. 112. 110907–110907. 2 indexed citations
3.
Xing, Zeyu, Yuting Hong, Lu Ye, et al.. (2023). Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell data. Frontiers in Oncology. 13. 1186858–1186858. 4 indexed citations
4.
5.
Feng, Kexin, et al.. (2023). Role of aggressive locoregional surgery in treatment strategies for ipsilateral supraclavicular lymph node metastasis of breast cancer: a real-world cohort study. Frontiers in Molecular Biosciences. 10. 1248410–1248410. 2 indexed citations
6.
Jia, Ziqi, Menglu Zhang, Gang Liu, et al.. (2022). Cost-Effectiveness Analysis of Imaging Modalities for Breast Cancer Surveillance Among BRCA1/2 Mutation Carriers: A Systematic Review. Frontiers in Oncology. 11. 763161–763161. 3 indexed citations
7.
Xing, Zeyu, et al.. (2021). Expression and prognostic value of CDK1, CCNA2, and CCNB1 gene clusters in human breast cancer. Journal of International Medical Research. 49(4). 1220780199–1220780199. 21 indexed citations
8.
Xing, Zeyu, Menglu Zhang, Xin Wang, et al.. (2021). Silencing of Nek2 suppresses the proliferation, migration and invasion and induces apoptosis of breast cancer cells by regulating ERK/MAPK signaling. Journal of Molecular Histology. 52(4). 809–821. 17 indexed citations
9.
Xing, Zeyu, Xin Wang, Jiaqi Liu, et al.. (2021). Effect of MiR‐210 on the Chemosensitivity of Breast Cancer by Regulating JAK‐STAT Signaling Pathway. BioMed Research International. 2021(1). 7703159–7703159. 15 indexed citations
10.
Xing, Zeyu, Menglu Zhang, Jiaqi Liu, et al.. (2021). Overexpression of IncRNA SAMMSON Promotes Triple-Negative Breast Cancer Cell Proliferation by Interacting with p53. Critical Reviews in Eukaryotic Gene Expression. 31(6). 1–8. 5 indexed citations
11.
Zhang, Menglu, Jiaqi Liu, Gang Liu, et al.. (2021). Anti-vascular endothelial growth factor therapy in breast cancer: Molecular pathway, potential targets, and current treatment strategies. Cancer Letters. 520. 422–433. 24 indexed citations
12.
Jia, Ziqi, Jiaxin Li, Yuelun Zhang, et al.. (2021). Contralateral risk-reducing local therapy in breast cancer patients with BRCA1/2 mutations: systemic review and meta-analysis. Cancer Cell International. 21(1). 512–512. 9 indexed citations
13.
Xing, Zeyu, Menglu Zhang, Jiaqi Liu, et al.. (2021). LINC00337 induces tumor development and chemoresistance to paclitaxel of breast cancer by recruiting M2 tumor-associated macrophages. Molecular Immunology. 138. 1–9. 25 indexed citations
14.
Zhang, Menglu, Xiangzhi Meng, Changyuan Guo, et al.. (2020). Clinicopathological Relevance and Prognostic Value of Androgen Receptor in Mammary Paget’s Disease with Underlying Invasive Ductal Carcinoma. Oncology Research and Treatment. 43(7-8). 346–353. 1 indexed citations
15.
Wang, Jie, Ying Song, Jiaqi Liu, et al.. (2020). Clinical Application and Feasibility of MRI-Guided Breast Biopsy of Breast Minimal Lesions in Chinese Population. Frontiers in Oncology. 10. 257–257. 1 indexed citations
16.
Xing, Zeyu, et al.. (2020). Hsa_circ_0069094 accelerates cell malignancy and glycolysis through regulating the miR-591/HK2 axis in breast cancer. Cellular Signalling. 79. 109878–109878. 19 indexed citations
17.
Feng, Kexin, Xiangzhi Meng, Jiaqi Liu, et al.. (2020). Update on intraoperative radiotherapy for early-stage breast cancer.. PubMed. 10(7). 2032–2042. 4 indexed citations
18.
Kong, Xiangyi, Kai Zhang, Xiangyu Wang, et al.. (2019). <p>Mechanism of trastuzumab resistance caused by HER-2 mutation in breast carcinomas</p>. Cancer Management and Research. Volume 11. 5971–5982. 21 indexed citations
19.
Liu, Jiaqi, Xin Wang, Wenyan Wang, et al.. (2018). Multi-clonal mutation signatures in primary breast malignancies and their axillary lymph node metastases.. Journal of Clinical Oncology. 36(15_suppl). e13526–e13526.
20.
Wang, Jing, et al.. (2017). A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?. PLoS ONE. 12(8). e0183012–e0183012. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samaneh Adelian Breakdown of academic impact, for papers by Rongxia Liao Breakdown of academic impact, for papers by Federico Lucantoni Breakdown of academic impact, for papers by Zhousan Zheng Breakdown of academic impact, for papers by Giulia Brisotto Breakdown of academic impact, for papers by Yue‐Ju Li Breakdown of academic impact, for papers by Brijesh Kumar Breakdown of academic impact, for papers by Hongchao Tang Breakdown of academic impact, for papers by Wu-Ping Zheng Breakdown of academic impact, for papers by Anna Tyutyunnykova
Rankless by CCL
2026